Literature DB >> 18040243

Untoward outcomes in 25-gauge versus 20-gauge vitreoretinal surgery.

Saad Shaikh1, Son Ho, Preston P Richmond, John C Olson, C Durham Barnes.   

Abstract

PURPOSE: This study compares the incidence of complications in eyes undergoing 25-gauge versus 20-gauge vitreoretinal procedures.
METHODS: Retrospective case series. A chart review of consecutive patients who underwent primary 25-gauge (129 eyes) and 20-gauge (129 eyes) vitreoretinal surgery by four surgeons at a single center between September 2002 and November 2005 was conducted.
RESULTS: Mean follow-up was 9.1 +/- 4.9 months in 25-gauge eyes and 14.3 +/- 8.4 months in 20-gauge eyes (P < 0.01). Intraoperative complications were mainly rhegmatogenous in nature and occurred at statistically similar incidence (4.7% in 25-gauge eyes, 6.9% in 20-gauge eyes). Postoperative complications that were significantly associated with surgical method included hypotony and serous choroidal effusions (7.9% in 25-gauge eyes, 1.6% in 20-gauge eyes, P = 0.02). Other postoperative complications noted included retinal tears and detachments (5.4% in 25-gauge eyes, 4.7% in 20-gauge eyes), persistent vitreous hemorrhage (5.4% in each group), and new vitreous hemorrhage (3.9% in 25-gauge eyes, 0.8% in 20-gauge eyes). Endophthalmitis was noted only in 25-gauge eyes in 2 cases (1.6%). Cataract progression occurred at similar rates in both groups (46%).
CONCLUSION: 25-gauge surgery is associated with a significantly greater incidence of postoperative serous choroidal effusions and hypotony. Of particular concern in 25-gauge surgery is the increased risk of associated endophthalmitis. Operative indications and case selection may be important in minimizing the tendency toward certain postoperative events.

Entities:  

Mesh:

Year:  2007        PMID: 18040243     DOI: 10.1097/IAE.0b013e3180592bb7

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  9 in total

1.  Outcomes of 25-gauge vitrectomy for proliferative diabetic retinopathy.

Authors:  Mahmoud Mohamed Farouk; Takeshi Naito; Khulood Mohammed Sayed; Toshihiko Nagasawa; Takashi Katome; Gamal Radwan; Ahmad Abdallah; Mohamed Elagouz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-09-17       Impact factor: 3.117

2.  Incidence of endophthalmitis after 20-gauge vs 23-gauge vs 25-gauge pars plana vitrectomy.

Authors:  Ingrid U Scott; Harry W Flynn; Nur Acar; Sundeep Dev; Saad Shaikh; Robert A Mittra; J Fernando Arevalo; Andres Kychenthal; Allen Kunselman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-09-18       Impact factor: 3.117

3.  Surgical outcomes of 23-gauge vitrectomy for the management of lens fragments dropped into the vitreous cavity during cataract surgery.

Authors:  Kyung Min Koh; Hyoung Seok Kim; Han Joo Cho; Young Ju Lew; Moon Jung Choi; Jung Il Han; Sung Won Cho; Chul Gu Kim; Tae Gon Lee; Jong Woo Kim; Su Jin Yoo
Journal:  Saudi J Ophthalmol       Date:  2014-02-03

4.  Evaluation of mechanical closure resistance of sutureless vitrectomy sclerotomies after conjunctival cauterization with bipolar diathermy forceps.

Authors:  Javier Benitez-Herreros; Lorenzo Lopez-Guajardo; Miguel Vazquez-Blanco; Valeria Opazo-Toro; Agustin Silva-Mato
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-12-15       Impact factor: 3.117

5.  Non-vitrectomizing surgery for idiopathic macular pucker using a 25-gauge synergetics high-flow infusion with a 27-gauge light (Photon II, Synergetics USA, Inc.).

Authors:  Cesare Mariotti; Francesca Viti; Piergiorgio Neri
Journal:  Int Ophthalmol       Date:  2009-09-02       Impact factor: 2.031

6.  Diabetic Vitrectomy is Over and the Retina Remains Attached; What is Next?

Authors:  Mehdi Modarres-Zadeh
Journal:  J Ophthalmic Vis Res       Date:  2010-04

Review 7.  Endophthalmitis following pars plana vitrectomy: a literature review of incidence, causative organisms, and treatment outcomes.

Authors:  Vivek Pravin Dave; Avinash Pathengay; Stephen G Schwartz; Harry W Flynn
Journal:  Clin Ophthalmol       Date:  2014-10-31

8.  In vivo comparison of 23- and 25-gauge sutureless vitrectomy incision architecture using spectral domain optical coherence tomography.

Authors:  Anderson Teixeira; Flavio A Rezende; Camila Salaroli; Nonato Souza; Benedito Antonio Sousa; Norma Allemann
Journal:  J Ophthalmol       Date:  2013-03-04       Impact factor: 1.909

9.  Subconjunctival Injection of Viscoelastic Material for Leaking Sclerotomy in Transconjunctival Sutureless Vitrectomy.

Authors:  Chung Hyun Lee; Soo Geun Joe; Sung Jae Yang
Journal:  J Ophthalmol       Date:  2016-04-06       Impact factor: 1.909

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.